Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role
This article was originally published in The Tan Sheet
Renowned clinical trialist and cardiologist will become deputy commissioner for medical products and tobacco, a complicated and challenging position.
You may also be interested in...
FDA’s new deputy commissioner is expected to advocate for innovation in clinical studies; Duke cardiologist has led numerous trials, including pivotal Xarelto study and Vytorin outcomes trial.
Renowned cardiologist and clinical trialist Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco.
President Obama highlights potential for personalized medicine in his State of the Union address and will seek a “major increase” in research and development funding.